Compare Tempus AI (TEM) vs Walmart Stores Inc (WMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempus AI vs Walmart Stores Inc — how do they compare? Tempus AI trades at $69.93 (market cap $12.58B), while Walmart Stores Inc trades at $110.4 (market cap $877.15B). The key difference: Walmart Stores Inc is far larger — about 69.7× Tempus AI's market cap, and Walmart Stores Inc pays a 0.9% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Tempus AI for 22 Days and Walmart Stores Inc for 101 Days on average.
| TEM | WMT | |
|---|---|---|
Market Cap | $12.58B | $877.15B |
Volume | 7,444,569 | 23,616,578 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $99.28 | $134.20 |
52-Week Low | $41.55 | $100.61 |
Typical Hold Time | 22 Days | 101 Days |
Enterprise Value | $13.21B | $939.38B |
Dividend Yield | — | 0.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Walmart (WMT) trades at $110.56, up 3.11% today, showing strong momentum after three consecutive quarterly earnings beats. The stock faces technical resistance near $110 with neutral indicators, while fundamentals reveal robust revenue growth to $681B (2025) and improving net margins to 2.85%. Recent news highlights expansion in AI capabilities, Marketplace growth exceeding 50%, and new Medicare Advantage partnerships, positioning Walmart for continued market share gains in the competitive retail sector.
Walmart presents a compelling long-term investment case with analyst consensus pointing to 16.5% upside to the $128.84 price target. However, the elevated P/E ratio of 39.2 and rising operational costs pose valuation and margin compression risks. Investors should weigh the company's digital transformation success against potential consumer spending pressures and inflationary headwinds affecting retail profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →About Walmart Stores Inc
Walmart Inc. operates discount stores, supercenters, and neighborhood markets. The Company offers merchandise such as apparel, house wares, small appliances, electronics, musical instruments, books, home improvement, shoes, jewelry, toddler, games, household essentials, pets, pharmaceutical products, party supplies, and automotive tools. Walmart serves customers worldwide.
Read more on WMT →
